Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 9,988,479 | 10,572,170 | 11,039,590 | 9,828,087 | 9,481,533 |
| Cost of Goods | 3,128,314 | 3,628,730 | 3,353,131 | 3,174,077 | 2,967,975 |
| Gross Profit | 6,860,165 | 6,943,439 | 7,686,462 | 6,654,010 | 6,513,559 |
| Operating Expenses | 5,311,688 | 5,755,701 | 5,252,546 | 5,057,696 | 4,663,412 |
| Operating Income | 1,548,792 | 1,188,469 | 2,434,047 | 1,596,391 | 1,851,121 |
| Interest Expense | 116,774 | 117,656 | 121,056 | 117,721 | 118,293 |
| Other Income | 83,586 | -220,291 | -29,384 | 3,300 | 19,183 |
| Pre-tax Income | 1,515,604 | 850,522 | 2,283,608 | 1,481,969 | 1,752,011 |
| Income Tax | 229,860 | 802,623 | 484,224 | 301,455 | 358,075 |
| Net Income Continuous | 1,285,743 | 47,900 | 1,799,384 | 1,180,515 | 1,393,936 |
| Minority Interests | 35,647 | 35,793 | 31,733 | 33,006 | 36,234 |
| Net Income | $1,250,096 | $12,106 | $1,767,651 | $1,147,509 | $1,357,702 |
| EPS Basic Total Ops | 0.50 | 0.20 | 0.74 | 0.45 | 2.41 |
| EPS Basic Continuous Ops | 0.52 | 0.02 | 0.72 | 0.47 | 0.55 |
| EPS Diluted Total Ops | 0.50 | 0.17 | 0.74 | 0.45 | 2.41 |
| EPS Diluted Continuous Ops | 0.52 | 0.01 | 0.72 | 0.47 | 0.55 |
| EBITDA(a) | $1,548,792 | $1,188,469 | $2,434,047 | $1,596,391 | $1,851,121 |